EMS Pharma Surpasses Pharma Giants in Generics War

“EMS is leading the domestic market with 12% share overtakes prominent players such as Sanofi, Novartis and Roche”, says RNCOS.


Noida, UP -- (SBWIRE) -- 02/11/2015 -- According to a new research report by RNCOS entitled, "Brazil Pharmaceutical Market Outlook 2018", the Pharmaceutical industry of Brazil is a conglomerate market of domestic and international companies. As long as leading pharmaceutical players have been grappled with expiring patents and pricing pressures in developed markets, they are starting to expect more from emerging markets like Brazil. As in Brazil, the Ministry of Health is encouraging local manufacturers with reduced drug prices policies, increasing research and development; and boosting generics development. Among all the players competing in the domestic pharmaceutical market, foreign players such as Sanofi, Novartis, Merck, Roche, GSK and local companies such as Ache Laboratories, Hypermarcas, Eurofarma; EMS Pharma has emerged as a leader in the Brazilian Pharmaceutical Market.

The company surpassed various national as well as international players with 12% share in the domestic pharmaceutical market. Also, EMS has registered highest number of Generics Drugs till last year in contrast to the most prominent international giants such as Sanofi, Pfizer and Novartis. EMS has been the first Brazilian laboratory to produce generic drugs in 2000. EMS portfolio consists of over 2000 products forms of Generic and similar drugs which account for the largest part of the company's revenues.

The report is spread in over 90 pages and provides an in-depth research and rational analysis of the current status and future prospect of the Brazilian Pharmaceutical industry. The study presents a transparent picture about different pharma segments such as Generics, OTC and Prescription Drugs including the factors affecting their growth. The research further covers Pharmaceutical Production, Therapeutic Segments, Growth Drivers and Challenges as well as Mergers and Acquisitions. The report also covers detailed information about active market players in the Brazil pharmaceutical industry, including domestic and foreign players to enable the clients understand the market structure and its growth during the forecasted period. In brief, the report covers all the necessary aspects of the Brazilian Pharmaceutical market, providing an in-depth research and prudent analysis of the key segments.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM726.htm

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

RNCOS is a leading industry research and consultancy firm incorporated in 2002. As a pioneer in syndicate market research, our vision is to be a global leader in the industry research space by providing research reports and actionable insights to companies across a range of industries such as Healthcare, IT and Telecom and Retail etc. We offer comprehensive industry research studies, bespoke research and consultancy services to Fortune 1000, Trade associations, and Government agencies worldwide.